Use of an MMP28 inhibitor for increasing myelination

Details for Australian Patent Application No. 2008242375 (hide)

Owner Eli Lilly and Company

Inventors Werner, Sean Richard

Agent Spruson & Ferguson

Pub. Number AU-B-2008242375

PCT Pub. Number WO2008/130814

Priority 60/976,570 01.10.07 US; 60/912,433 18.04.07 US

Filing date 4 April 2008

Wipo publication date 30 October 2008

Acceptance publication date 14 April 2011

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/130814 Priority application(s): WO2008/130814

14 April 2011 Application Accepted

  Published as AU-B-2008242375

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008242417-Films comprising a plurality of polymers

2008242373-Mandoline with adjustable cutting depth